Live Quote · NASDAQSCTLHealthcare· Drug Manufacturers - Specialty & Generic

Societal CDMO, Inc.

$1.10 0.92%(+$0.01)
TickerSpark Score
67/100
Solid
65
Valuation
45
Profitability
70
Growth
56
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SCTL research report →

52-Week Range82% of range
Low
$0.26
Current
$1.10
High
$1.28
Company Overviewwww.societalcdmo.com

About the company

Societal CDMO, Inc. , an organization founded in Exton, Pennsylvania, in 2007, functions as a contract development and manufacturing partner for the global pharmaceutical industry. Formerly known as Recro Pharma, Inc.

CEO
J. David Enloe Jr.
IPO
2014
Employees
258
HQ
Exton, PA, US

Price Chart

+2.80% · this period
$1.12$0.71$0.30Apr 06Oct 06Apr 08
Valuation
Market Cap
$116.13M
P/E
-7.86
P/S
1.23
P/B
1.79
EV/EBITDA
26.49
Div Yield
0.00%
Profitability
Gross Margin
19.54%
Op Margin
-1.86%
Net Margin
-14.03%
ROE
-22.40%
ROIC
-1.24%
Growth & Income
Revenue
$94.64M · 4.90%
Net Income
$-13,274,000 · 33.23%
EPS
$-0.14 · 58.82%
Op Income
$-1,759,000
FCF YoY
3.50%
Performance & Tape
52W High
$1.28
52W Low
$0.26
50D MA
$0.78
200D MA
$0.61
Beta
1.58
Avg Volume
998.39K

Get TickerSpark's AI analysis on SCTL

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Apr 8, 24Arens Mathew Paulsell1,250,000
Apr 8, 24Arens Mathew Paulsell20,000
Apr 8, 24Arens Mathew Paulother19,676,396
Apr 8, 24Weisman Wayneother234,982
Apr 8, 24Weisman Waynesell73,620
Apr 8, 24Weisman Waynesell118,182
Apr 8, 24Weisman Waynesell27,229
Apr 8, 24Reasons Bryan M.other217,429
Apr 8, 24Reasons Bryan M.sell118,182
Apr 8, 24Reasons Bryan M.sell27,229
Coverage · SCTL

Our SCTL coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on SCTL yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate SCTL report →
Internal Compare

Similar companies

Peers in the same neighborhood.